Sanofi
Actelion acquisition hokey-cokey continues with J&J returning to table
December 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi
The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …
Sanofi eyes Actelion merger as J&J backs down
December 14, 2016Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi
After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …
Scottish Medicines Consortium approves Sanofi’s prostate cancer drug
December 12, 2016Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer
Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …
Neurodegenerative market to be worth $45 billion by 2022
December 12, 2016Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative
Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …
Sanofi and Novo to face off in diabetes sphere following FDA approvals
November 22, 2016Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes
Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …
FDA rejects Sarilumab due to production facility issues
October 31, 2016Manufacturing and Production, Sales and Marketing FDA, Regeneron, Sanofi, sarilumab
The US Food and Drugs administration has decided to reject the application for Sarilumab, Regeneron and Sanofi’s rheumatoid arthritis treatment, …
Sanofi forms new alliance to fight zika in Brazil
October 27, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Zika
Sanofi has teamed up with Brazilian research institute Fiocruz to accelerate development of a zika vaccine.This is another step in …
Price hiking: US pharma’s elephant in the room
October 26, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes
Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …
Sanofi lowers Q3 sales figures from 2015
October 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cipro, Plavix, Sanofi, financial results
Sanofi lowered its aggregate sales figure for Q3 2016 from €9.59 billion to €9.46 billion ahead of the release of …
Sanofi’s dengue vaccine scores 11th worldwide approval in Singapore
October 4, 2016Sales and Marketing Sanofi, dengue, drug approval
Sanofi Pasteur, the vaccines unit of the wider French firm, has announced that its dengue vaccine Dengvaxia has secured market …
Sanofi secures $43 million government funding for zika vaccine development
September 27, 2016Manufacturing and Production, Research and Development BARDA, Sanofi, Zika
The US Department of Health and Human Services approved $43.18 million to fund Sanofi’s development of a zika vaccine, the …
Sanofi reveals promising data for relapsing remitting MS treatment
September 20, 2016Manufacturing and Production, Research and Development RRMS, Sanofi, relapsing remitting multiple sclerosis, relapsing-remitting multiple sclerosis
Sanofi Genzyme, the speciality care global business unit of the French pharma firm announced six-year investigational data on Lemtrada (alemtuzumab) …
Sanofi accuses MSD of US patent infringement
September 19, 2016Sales and Marketing MSD, Sanofi, lawsuit
Sanofi has filed a suit against MSD in the United States District Court for the District of Delaware accusing the …
Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
New immunology and inflammation research global head and North American CSO for Sanofi
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment
Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
